Licensing biological material is critical to the success of preclinical research—join us to gain insights and avoid costly pitfalls.
Licensing biological material for preclinical research can be challenging and requires a clear understanding of the legal, ethical, and regulatory frameworks involved. In this webinar, we will explore key considerations for ensuring that biological material is properly licensed for use in both research and commercial settings, helping you avoid potential financial and reputational damage.
This interactive session, hosted by Scientist.com and featuring experts from Crown Bioscience, will cover topics such as best practices for tracking and managing licenses, legal frameworks, and case studies on successful agreements. Gain practical knowledge on navigating licensing challenges, and learn how to protect your research from potential legal risks.
Key Topics Include:
- Understand the critical importance of biological material licensing in preclinical research.
- Learn best practices for managing licensing agreements.
- Gain insights into intellectual property (IP) and other contractual considerations, including patents and compliance.
- Explore real-world case studies on navigating licensing challenges in CROs and beyond.
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.
Presenters
Senior Director of Corporate Development & Strategy
Crown Bioscience
In his current role, Jim manages Crown Bioscience’s corporate partnerships in North America and Europe, which includes licensing in cell lines, organoid and PDX models from academic, non-profit and industry partners. His previous roles include Business Development at Crown Bioscience and other CROs, as well as Product Management and sales roles at both established as well as startup Life Science companies. Jim has an undergraduate degree in Biology from Holy Cross and an MBA from Boston College.
Senior Category Director, Human Biological Samples
Scientist.com
Maria joined Scientist.com in 2019 and is now the Senior Category Director for Human Biological Samples and is based in Manchester, UK. Her role includes supporting the sourcing of Human Biological Samples for research globally.
Prior to Scientist.com, Maria managed the Liver Transplant Program for one of London’s transplant centers. She also worked with UCL sourcing fresh human tissue for research. She has additional experience with clinical practices (GCP), donor identification, donor consent, samples collections, ethics approvals, processing and shipping requirements.
Production Partner
Crown Bioscience
Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology.
Additional Content From Crown Bioscience
Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Learn to integrate PK/PD modeling and strategic biomarkers to bridge the translational gap. Improve clinical predictability for NCEs, ADCs, and large molecules in this technical webinar.
Human Biological Samples in Research: Quality, Compliance, and Clinical Relevance
In this webinar, three experts discuss best practices for ensuring specimen integrity, leveraging biobanking for oncology breakthroughs, and enriching clinical data for translational research.
Beyond Checkpoints: Strategic Use of CDX Models in Emerging IO Therapies
Learn how enhanced CDX models with humanized immune systems improve preclinical-to-clinical success in emerging immuno-oncology therapies.
Additional Content From Scientist.com
How to Avoid Expensive Redesign Cycles in Antibody Discovery
Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control
Learn how to scale the production of MSCs and extracellular vesicles using bioreactor control and real-time monitoring for more consistent therapies.
From Clinical Data to Actionable Assets for Pharmaceutical R&D
In this webinar, learn to transform raw clinical and biobanking data into research-ready assets to accelerate pharmaceutical R&D.
Related Content
Improving Preclinical Decision-Making in Obesity and CKD with Translational In Vivo Phenotyping
Join us to learn how in-depth in vivo phenotyping using patient-relevant models can improve preclinical decision-making.
Detecting Early Synaptic Failure in Prion Disease Using Organoid Models
Join our webinar to see how early synaptic dysfunction can be captured with long-term organoid electrophysiology using Mesh MEA.